Amgen
The Hybrid Modality Group at Amgen is seeking an Associate Scientist in organic and conjugation chemistry to develop new hybrid therapeutics. This role involves working at the intersection of synthetic chemistry, biochemistry, and chemical biology within a state-of-the-art research facility. Key duties include synthesizing small molecule payloads and linkers for antibody-drug conjugates and characterizing protein-peptide conjugates for clinical development.
Headquarters
Thousand Oaks, California, United States
Company Size
10001+ employees
Founded
1980
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Amgen.
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained
1 day ago
Research Fellow in Organic Chemistry
Nanyang Technological University
Senior Associate Scientist, R&D Chemistry
Regeneron Pharmaceuticals
ADC Research and Development Scientist
BioNTech
Research Fellow in Organic Chemistry
Nanyang Technological University
Senior Scientist (Synthetic Chemistry)
AstraZeneca
Scientist II, Bioconjugation Chemist
biomarin